Editorial
Seguridad cardiovascular de los nuevos fármacos para la diabetes tipo 2
Cardiovascular safety of new type 2 diabetes drugs
A. Hormigo Pozo, J. Mancera Romero
Autor para correspondencia
Grupo de Trabajo Diabetes Semergen
Leído
6859
Vecesse ha leído el artículo
2342
Total PDF
4517
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 6 | 1 | 7 |
| 2025 11 | 33 | 15 | 48 |
| 2025 10 | 31 | 11 | 42 |
| 2025 9 | 21 | 17 | 38 |
| 2025 8 | 34 | 18 | 52 |
| 2025 7 | 18 | 5 | 23 |
| 2025 6 | 12 | 2 | 14 |
| 2025 5 | 22 | 5 | 27 |
| 2025 4 | 14 | 3 | 17 |
| 2025 3 | 25 | 7 | 32 |
| 2025 2 | 18 | 4 | 22 |
| 2025 1 | 31 | 3 | 34 |
| 2024 12 | 25 | 5 | 30 |
| 2024 11 | 21 | 2 | 23 |
| 2024 10 | 19 | 3 | 22 |
| 2024 9 | 27 | 5 | 32 |
| 2024 8 | 19 | 4 | 23 |
| 2024 7 | 15 | 3 | 18 |
| 2024 6 | 17 | 7 | 24 |
| 2024 5 | 15 | 4 | 19 |
| 2024 4 | 24 | 1 | 25 |
| 2024 3 | 27 | 5 | 32 |
| 2024 2 | 23 | 4 | 27 |
| 2024 1 | 15 | 2 | 17 |
| 2023 12 | 21 | 2 | 23 |
| 2023 11 | 15 | 6 | 21 |
| 2023 10 | 25 | 3 | 28 |
| 2023 9 | 16 | 0 | 16 |
| 2023 8 | 27 | 0 | 27 |
| 2023 7 | 41 | 4 | 45 |
| 2023 6 | 15 | 1 | 16 |
| 2023 5 | 19 | 3 | 22 |
| 2023 4 | 9 | 5 | 14 |
| 2023 3 | 12 | 3 | 15 |
| 2023 2 | 8 | 7 | 15 |
| 2022 1 | 10 | 1 | 11 |
| 2022 12 | 13 | 7 | 20 |
| 2022 11 | 29 | 4 | 33 |
| 2022 10 | 28 | 7 | 35 |
| 2022 9 | 22 | 7 | 29 |
| 2022 8 | 20 | 10 | 30 |
| 2022 7 | 17 | 10 | 27 |
| 2022 6 | 20 | 8 | 28 |
| 2022 5 | 27 | 6 | 33 |
| 2022 4 | 30 | 20 | 50 |
| 2022 3 | 28 | 8 | 36 |
| 2022 2 | 37 | 5 | 42 |
| 2021 1 | 52 | 8 | 60 |
| 2021 12 | 22 | 11 | 33 |
| 2021 11 | 58 | 7 | 65 |
| 2021 10 | 19 | 10 | 29 |
| 2021 9 | 14 | 12 | 26 |
| 2021 8 | 11 | 7 | 18 |
| 2021 7 | 22 | 10 | 32 |
| 2021 6 | 15 | 9 | 24 |
| 2021 5 | 19 | 16 | 35 |
| 2021 4 | 70 | 25 | 95 |
| 2021 3 | 36 | 18 | 54 |
| 2021 2 | 36 | 16 | 52 |
| 2020 1 | 20 | 15 | 35 |
| 2020 12 | 23 | 11 | 34 |
| 2020 11 | 22 | 7 | 29 |
| 2020 10 | 11 | 13 | 24 |
| 2020 9 | 21 | 8 | 29 |
| 2020 8 | 39 | 19 | 58 |
| 2020 7 | 29 | 10 | 39 |
| 2020 6 | 26 | 10 | 36 |
| 2020 5 | 18 | 13 | 31 |
| 2020 4 | 25 | 6 | 31 |
| 2020 3 | 32 | 8 | 40 |
| 2020 2 | 36 | 5 | 41 |
| 2020 1 | 31 | 14 | 45 |
| 2019 12 | 64 | 11 | 75 |
| 2019 11 | 35 | 8 | 43 |
| 2019 10 | 31 | 9 | 40 |
| 2019 9 | 32 | 13 | 45 |
| 2019 8 | 27 | 8 | 35 |
| 2019 7 | 27 | 17 | 44 |
| 2019 6 | 107 | 50 | 157 |
| 2019 5 | 244 | 127 | 371 |
| 2019 4 | 51 | 63 | 114 |
| 2019 3 | 25 | 13 | 38 |
| 2019 2 | 28 | 21 | 49 |
| 2019 1 | 15 | 26 | 41 |
| 2018 12 | 14 | 25 | 39 |
| 2018 11 | 38 | 40 | 78 |
| 2018 10 | 36 | 9 | 45 |
| 2018 9 | 27 | 12 | 39 |
| 2018 8 | 8 | 21 | 29 |
| 2018 7 | 11 | 16 | 27 |
| 2018 6 | 9 | 27 | 36 |
| 2018 5 | 15 | 22 | 37 |
| 2018 4 | 10 | 22 | 32 |
| 2018 3 | 15 | 13 | 28 |
| 2018 2 | 15 | 16 | 31 |
| 2018 1 | 6 | 12 | 18 |
| 2017 12 | 8 | 11 | 19 |
| 2017 11 | 4 | 21 | 25 |
| 2017 10 | 14 | 14 | 28 |
| 2017 9 | 8 | 20 | 28 |
| 2017 8 | 20 | 5 | 25 |
| 2017 7 | 6 | 15 | 21 |
| 2017 6 | 8 | 22 | 30 |
| 2017 5 | 14 | 24 | 38 |
| 2017 4 | 12 | 29 | 41 |
| 2017 3 | 20 | 41 | 61 |
| 2017 2 | 18 | 21 | 39 |
| 2016 1 | 18 | 10 | 28 |
| 2016 12 | 30 | 18 | 48 |
| 2016 11 | 32 | 30 | 62 |
| 2016 10 | 37 | 25 | 62 |
| 2016 9 | 38 | 29 | 67 |
| 2016 8 | 25 | 15 | 40 |
| 2016 7 | 35 | 1 | 36 |
| 2016 6 | 32 | 32 | 64 |
| 2016 5 | 45 | 53 | 98 |
| 2016 4 | 27 | 38 | 65 |
| 2016 3 | 43 | 36 | 79 |
| 2016 2 | 31 | 46 | 77 |
| 2015 1 | 39 | 53 | 92 |
| 2015 12 | 37 | 41 | 78 |
| 2015 11 | 38 | 28 | 66 |
| 2015 10 | 51 | 36 | 87 |
| 2015 9 | 44 | 28 | 72 |
| 2015 8 | 47 | 19 | 66 |
| 2015 7 | 28 | 15 | 43 |
| 2015 6 | 31 | 14 | 45 |
| 2015 5 | 30 | 18 | 48 |
| 2015 4 | 48 | 33 | 81 |
| 2015 3 | 36 | 14 | 50 |
| 2015 2 | 32 | 19 | 51 |
| 2015 1 | 44 | 11 | 55 |
| 2014 12 | 65 | 17 | 82 |
| 2014 11 | 30 | 8 | 38 |
| 2014 10 | 44 | 16 | 60 |
| 2014 9 | 51 | 21 | 72 |
| 2014 8 | 37 | 17 | 54 |
| 2014 7 | 48 | 16 | 64 |
| 2014 6 | 47 | 12 | 59 |
| 2014 5 | 61 | 11 | 72 |
| 2014 4 | 129 | 48 | 177 |
| 2014 3 | 377 | 139 | 516 |
Mostrar todo
